A blood score at menopause that tracks later brain health

Lifespan.io · Article

Researchers mapped blood proteins across the menopausal transition in healthy midlife women and found 16 proteins - spanning inflammation, synaptic, metabolic and Alzheimer-related processes - that shift with menopause stage rather than with age alone. Combined into a proteomic score, those shifts were associated in separate older cohorts with worse later cognition and higher Alzheimer dementia risk.

Key takeaways:

• The signal is stage, not birthday: perimenopause and postmenopause each raised the score in steps, and 9 of the proteins that could be checked replicated in a much larger UK Biobank sample of almost 3,000 women
• Two hormonal threads separate out: some proteins tracked falling estradiol, others tracked rising FSH, suggesting distinct pathways rather than one generic menopause effect
• The discovery sample was small (80 women plus 36 men for comparison); the value so far is risk stratification decades early, not prediction for any one woman

Hype check: Proven - a stage-linked protein signature, partly replicated at scale, associated with later cognitive outcomes across four independent cohorts. Promising - the score as an early risk marker and a way to time interventions. Marketing - any framing of this as a dementia prediction test for individuals today; it is a research association, not a clinical test.